Immunoadsorption in the treatment of Acquired Haemophilia

Atherosclerosis Supplements

Volumn 10, Issue 5, 2009, Pages 122-125

  Zeitler, Heike ^a   Ulrich Merzenich, Gudrun ^a   Panek, Darius ^a   Goldmann, Georg ^a   Vidovic, Natascha ^a   Brackmann, Hans Hermann ^a   Oldenburg, Johannes ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Acquired haemophilia; APTT; FVIII; Immune tolerance induction MBMP protocol; Immunmodulation; Immunoadsorption

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AZATHIOPRINE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; PREDNISOLONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACQUIRED HEMOPHILIA; ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPLEMENT BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; HEMOPHILIA; HUMAN; IMMUNOADSORPTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MODIFIED BONN MALMO PROTOCOL; MORTALITY; MULTIPLE CYCLE TREATMENT; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REMISSION; TREATMENT OUTCOME;

AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; FACTOR VIII; HEMOPHILIA A; HEMORRHAGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 72649105732     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(09)71825-2     Document Type: Article

References (18)

1. Huth-Kühne A., Baudo F., Collins P., Ingerslev J., Kessler C.M., Levesque H., et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 94 4 (2009) 566-575
2. Collins P.W. Treatment of acquired hemophilia. J Thromb Haemost 5 (2007) 893-900
3. Zeitler H., Ulrich-Merzenich G., Hess L., et al. Treatment of acquired hemophilia by the Bonn-Malmö Protocol: documentation of an in vivo immunomodulating concept. Blood 105 (2005) 2287-2293
4. Ng H.J., Tan D.C., and Lee L.H. Treatment and outcome of acquired haemophilia A with a standard conventional regime in a cohort without associated conditions. Haemophilia 12 (2006) 423-428
5. Franchini M., et al. Acquired factor VIII inhibitors. Blood 112 2 (2008) 250-255
6. Huth-Kühne A., et al. Cautions and caveats to the treatment of acquired hemophilia A. Haematologica 94 8 (2009) 1181-1182
7. nd Edition Excerpta Medica, Juni 1995.
8. Zeitler H, et al. The relevance of the bleeding severity in the treatment of acquired haemophilia-an update of a single -centre experience in 67 patients. Haemophilia 2008 Nov 14 Epub ahead of print.
9. Giles A.R., Verbruggen B., Roivard G.E., Walker I., and the Association of Haemophilia Centre of Canada. A detailed comparison of the performance of the standard versus Nijmegen modification of the Bethesda assay in detecting factor VIII: inhibitors in the haemophilia a population of Canada. Thromb Haemost 79 (1998) 872-875
10. Sumner M.J., Geldziler B.D., Pedersen M., and Seremetis S. Treatment of acquired haemophilie with recombinant activated FVII: a critical appraisal. Haemophilia 13 (2007) 451 451
11. Delgado J., Yuste V., Navarro F., and Villar A. Acquired Haemophilia: Review and Meta-Analysis focused on therapy and prognostic factors. Brit J Haematol 121 (2003) 21-35
12. Brackmann H.H., Oldenburg J., and Schwaab R. Immune tolerance for the treatment of factor VIII inhibitor - twenty years "Bonn protocol". Vox Sang 70 (1996) 30-35
13. Borg J., and Levesque H. Epidemiology and one year outcomes in patients with acquired haemophilia (AH) in France: the SACHA prospective Study. J Thromb Haemost Suppl 2 (2007) O-M-062
14. Bitting R.L., Bent S., Li Y., and Kohlwes J. The prognosis and treatment of acquired hemophilia: a systematic review and metaanalysis. Blood Coagul Fibrinolysis (2009) (jul 29) ahead of print.
15. Freiburghaus C., Berntrop E., Ekman M., Gunnarsson M., Kjellberg B.M., and Nilsson I.M. Immunoadsorption for removal of inhibitors: update on treatments in Malmö Lund between 1980 and 1995. Haemophilia 4 1 (1998) 16-20
16. Zeitler H., Ulrich- Merzenich G., Walger P., et al. Treatment of Factor VIII Inhibitors with Selective IgG Immunoadsorption - a Single Centre Experience in 50 Patients with Acquired Hemophilia. Transfusion Medicine and Hemotherapy 33 (2006) 160-164
17. Braun N: Fundamentals and Applications of Immunoadsorption; Chapter 3 Haemophilia in press Uni Med Verlag.
18. Sperr W.R., Lechner K., and Pabinger I. Rituximab for the treatment of acquired antibodies for factor VIII. Haematologica 92 (2007) 66-71